Facebook
Twitter
LinkedIn
ForwardFY 2024 Spring: Antineoplastic Therapy and Immunotherapy Course IR Nurse
This four-day course is designed to address the needs of the nursing and other oncology professionals in relation to antineoplastic and immunotherapies. It includes information on current and investigational pharmacotherapy, safe handling, administration of antineoplastic agents, and various issues concerning the management of patients receiving cancer therapy. Learners must attend all four days of class and pass an exam with 80% accuracy at the end of the course in order to claim credit for the course .
This course is NOT a certification course and is not intended to measure competency. Individual institutions are responsible for determining their own requirements for assessing clinical competency.
It is strongly recommended that attendees have taken the Foundations to Practice series prior to completing this course.
All courses are sponsored by UPMC Hillman Cancer Center.
The faculty consists of healthcare professionals with expertise in cancer care at UPMC.
Target Audience
Registered Nurses caring for the oncology patient.
Learning Objectives
Discuss the expectations related to class content and the participant’s professional responsibilities.
Discuss the roles of antineoplastic therapy and immunotherapy in the treatment of cancer.
Recall the pharmacology of different classes of antineoplastic or supportive therapies.
Recognize side effects and organ toxicities that patients may experience while receiving antineoplastic or supportive therapies.
Discuss management strategies for patients receiving antineoplastic or supportive therapies, including the prevention and treatment of toxicities and side effects.
Identify interventions to prevent chemotherapy errors.
Demonstrate that learning has occurred by achieving at least an 80% on the final exam.
Additional Information
| Attachment | Size |
|---|---|
 Kriner jamie 2023-2024.pdf | 298.96 KB |
| OConnor Lynne 2023-2024.pdf | 298.93 KB |
| AIS Chemo Spring 2024 IR nurses.pdf | 139.78 KB |
Nancy Birus RN, OCN
Clinical Education Specialist
UPMC Hillman Cancer Center
Amy DiMaggio, MSN, RN, CMSRN, OCN
Clinical Education Specialist
UPMC Hillman Cancer Center
Timothy George, PharmD, BCOP
Clinical Pharmacy Specialist
UPMC Hillman Cancer Center
Marissa Lamary, PA-C
Physician Assistant
UPMC Hillman Cancer Center/UPMC Shadyside
Brian Miller, PharmD
Manager, Investigational Drug Services Pharmacy
UPMC Hillman Cancer Center
Lynne O’Connor, MSN, RN, OCN
Clinical Education Specialist
UPMC Hillman Cancer Center
Alyssa Owens, MPAS, PA-C
Physician Assistant
UPMC Hillman Cancer Center
Linda Pfeifer, CRNP, RN
Nurse Practitioner
UPMC Hillman Cancer Center
Brittni Prosdocimo, MSN, RN, BMTCN
Advanced Clinical Education Specialist
UPMC Hillman Cancer Center
Markie Rearick, MSN, RN, BMTCN
Clinical Education Specialist
UPMC Shadyside
Ernest M. Sanchez, Pharm.D.
Lead Pharmacist of Oncology Operations, Department of Pharmacy
UPMC Shadyside Hospital
Trish Seaman, MSN, RN, CMSRN
Nurse Educator, Central PA
UPMC Hillman Cancer Center
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 14.25 contact hours.
To receive 14.25 contact hours, the learner must sign in, attend the entire activity, pass the course test with a score of 80% or greater and complete the activity evaluation.
Available Credit
- 14.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 14.25 Attendance